Correction: “The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms” Leukemia. 2022 Jul;36(7):1720–1748
2023 · Leukemia · 56 citations
https://doi.org/10.1038/s41375-023-01962-5
M
Motoko Yamaguchi
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
349
Papers
7.5K
Citations
43
h-index
98
i10-index
Motoko Yamaguchi is an academic researcher from Ritsumeikan University. The author has contributed to research in topics: Lymphoma Diagnosis and Treatment & Viral-associated cancers and disorders & CNS Lymphoma Diagnosis and Treatment. The author has an h-index of 43, co-authored 297 publications.
ORCID: 0000-0002-7094-6489Papers by this author
works<scp>R‐CHOP</scp> treatment for patients with advanced follicular lymphoma: Over 15‐year follow‐up of <scp>JCOG0203</scp>
2023 · British Journal of Haematology · 12 citations
https://doi.org/10.1111/bjh.19213
Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with high-dose methotrexate plus intrathecal chemotherapy for newly diagnosed intravascular large B-cell lymphoma (PRIMEUR-IVL): long-term results of a multicentre, single-arm, phase 2 trial
2025 · EClinicalMedicine · 5 citations
https://doi.org/10.1016/j.eclinm.2025.103078
HTA42 Vignette-Based Estimation of Utilities in Patients with Metastatic Breast Cancer in Japan
2024 · Value in Health · 1 citations
https://doi.org/10.1016/j.jval.2024.03.1393
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat